Table 3:

EUS/EGD findings in P/LP BRCA1, BRCA2, PALB2, and ATM carriers.

	Total (N = 64)	%
EUS findings
Any abnormality	28	44%
PDAC	2	3%
Mass	3	5%
Cyst	17	27%
Mass/cyst after initial EUS	5	8%
Parenchymal abnormality	10	16%
Heterogeneity	4	6%
Hyperechoic	2	3%
Lobularity	4	6%
Fatty	6	9%
EGD findings
Any abnormality	26	41%
Esophagitis	8	13%
Esophageal stricture	3	5%
Barrett’s esophagus	3	5%
Gastritis	10	16%
Gastric ulcer	2	3%
Gastric intestinal metaplasia	3	5%
Fundic gland polyp*	9	14%
Helicobacter pylori	1	2%

^*One individual had a fundic gland polyp with low grade dysplasia